Statement of Changes in Beneficial Ownership (4)
01 Março 2018 - 6:10PM
Edgar (US Regulatory)
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Split Rock Partners, LP
|
2. Issuer Name
and
Ticker or Trading Symbol
ENTELLUS MEDICAL INC
[
ENTL
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
__
X
__ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
10400 VIKING DR, SUITE 250
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/28/2018
|
(Street)
EDEN PRAIRIE, MN 55344
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock, $0.001 par value
|
2/28/2018
|
|
D
|
|
3156732
|
D
|
$24
(1)
|
0
|
D
(2)
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(1)
|
Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share.
|
(2)
|
The securities are owned directly by Split Rock Partners, LP ("SRP"). Voting and investment power over the securities is delegated to Split Rock Partners Management, LLC ("SRPM"), the general partner of SRP. SRPM has delegated voting and investment decisions to Michael Gorman, James Simons and David Stassen (collectively, the "General Partner Designees"), who require a two-thirds vote to act. Each of the General Partner Designees disclaims beneficial ownership of the securities except to the extent of any pecuniary interest therein.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Split Rock Partners, LP
10400 VIKING DR
SUITE 250
EDEN PRAIRIE, MN 55344
|
|
X
|
|
|
Split Rock Partners Management LLC
10400 VIKING DR
SUITE 250
EDEN PRAIRIE, MN 55344
|
|
X
|
|
|
Signatures
|
/s/Stacy M. Campbell-Kraft, Authorized Representative
|
|
3/1/2018
|
**
Signature of Reporting Person
|
Date
|
Stacy M. Campbell-Kraft, Authorized Representative
|
|
3/1/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
ENTELLUS MEDICAL INC (NASDAQ:ENTL)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
ENTELLUS MEDICAL INC (NASDAQ:ENTL)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre Entellus Medical, Inc. (delisted) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Entellus Medical Inc